A5000103084- Viral-associated cancers and disorders
- Lymphoma Diagnosis and Treatment
- Health Systems, Economic Evaluations, Quality of Life
- Diabetes Treatment and Management
- Global Cancer Incidence and Screening
- Inflammatory Bowel Disease
- Systemic Lupus Erythematosus Research
- Rabies epidemiology and control
- Biosimilars and Bioanalytical Methods
- Pharmacology and Obesity Treatment
- Multiple Sclerosis Research Studies
- Renal and Vascular Pathologies
- Organ Donation and Transplantation
- Innovation Policy and R&D
- Substance Abuse Treatment and Outcomes
- Human-Animal Interaction Studies
- Cancer-related molecular mechanisms research
- Economic and Financial Impacts of Cancer
- Obesity, Physical Activity, Diet
- T-cell and Retrovirus Studies
- Renal Transplantation Outcomes and Treatments
- Homelessness and Social Issues
- Alcohol Consumption and Health Effects
National Cancer Centre Singapore
2022
Washington University in St. Louis
2017
Despite improvements in outcomes for kidney transplant recipients the past decade, graft failure continues to impose substantial burden on patients. However, population-wide economic of has not been quantified. This study aims fill that gap by comparing from a simulation model patients which are at risk with an alternative is assumed be zero. Transitions through were estimated using Scientific Registry Transplant Recipients data 1987 2017. We lifetime costs, overall survival, and...
With lowering costs of sequencing and genetic profiling techniques, drivers can now be detected readily in tumors but current prognostic models for Natural-killer/T cell lymphoma (NKTCL) have yet to fully leverage on them prognosticating patients. Here, we used next-generation sequence 260 NKTCL tumors, trained a genomic model (GPM) with the mutations survival data from this retrospective cohort patients using LASSO Cox regression. The GPM is defined by mutational status 13 genes weakly...
To estimate the extent to which approvals of new pharmacological therapies were associated with cancer mortality in USA between 2000 and 2016.The analysis quantified drug across 15 tumor types highest incidence. Number a given time period for each was translated into treatment stock measure, defined as weighted sum indication since 1976. The primary outcome annual tumor-specific mortality, number deaths per 100,000 U.S. population. used multivariable ordinary least squares fixed effects...
Aims: Model how moving from current disease-modifying drug (DMD) prescribing patterns for relapsing-remitting multiple sclerosis (RRMS) observed in the United Kingdom (UK) to based on patient preferences would impact health outcomes over time.Materials and methods: A cohort-based Markov model was used measure effect of DMDs long-term individuals with RRMS. Data a discrete choice experiment were estimate market shares (i.e. preference shares). These real-world UK calculate behavior relapses,...
While substantial public health investment in anti-smoking initiatives has had demonstrated benefits on and fiscal outcomes, similar reducing obesity not been undertaken, despite the burden places society. Anti-obesity medications (AOMs) are poorly prescribed evidence that weight loss is sustained using other strategies alone.We used a simulation model to estimate potential impact of 100% uptake AOMs Medicare Medicaid spending, disability payments, taxes collected relative status quo with...
Abstract Date Presented 3/31/2017 This study evaluated the impact of a dog-training program on female prisoners. Few quantitative studies have assessed influence such programs this population. Our findings contribute preliminary evidence supporting efficacy these and suggest need for future research. Primary Author Speaker: Rebecca Kee Contributing Authors: Regina Abel, Julia Eckhoff